Live from the NIH registry
Studies recruiting near Santa Clarita right now
Top 25 of 2,368 recruiting studies, sorted by proximity — each links to its official registry page
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (29.1 mi)
· Sponsor: University of Pennsylvania
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Children's Hospital Los Angeles, Div. of Research Immunology/BMT (Adults and Pediatrics) — Los Angeles, California (29.1 mi)
· Sponsor: Pierre Fabre Medicament
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente - Panorama City — Panorama City, California (13.6 mi)
· Sponsor: SWOG Cancer Research Network
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma
Phase 1
Interventional 46 participants sought
University of Southern California — Los Angeles, California (29.1 mi)
· Sponsor: SciTech Development, Inc.
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Prostate Carcinoma
N/A
Observational 300 participants sought
Los Angeles General Medical Center — Los Angeles, California (29.1 mi)
· Sponsor: University of Southern California
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Group of Southern California — Los Angeles, California (29.1 mi)
· Sponsor: Pacific Edge Limited
Access to Genetic Testing in Underserved Patients With Cancer
Breast Carcinoma, Male Breast Carcinoma
N/A
Interventional 800 participants sought
USC / Norris Comprehensive Cancer Center — Los Angeles, California (29.1 mi)
· Sponsor: University of Southern California
Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease
Phase 1, Phase 2
Interventional 54 participants sought
UCLA TMS Clinical and Research Service — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
The Regents of the University of California, Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of Pittsburgh
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
UCLA Care — Los Angeles, California (29.1 mi)
· Sponsor: Westat
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Beverly Hills Cancer Center — Beverly Hills, California (24.4 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
UCLA Clinical & Translational Research Center (CTRC) — Los Angeles, California (29.1 mi)
· Sponsor: Eli Lilly and Company
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Global Research Management — Glendale, California (23.5 mi)
· Sponsor: Boehringer Ingelheim
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Low-Risk, Early Stage Breast Cancer
N/A
Interventional 400 participants sought
Glendale Adventist Medical Center d/b/a Adventist Health Glendale — Glendale, California (23.5 mi)
· Sponsor: IceCure Medical Ltd.
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
University of Southern California-Children's Hospital — Los Angeles, California (29.1 mi)
· Sponsor: University of Michigan
Regional Blocks for Lateral Condyle Fractures
Fractures, Closed, Humeral Fractures
Phase 4
Interventional 90 participants sought
Orthopaedic Institute for Children — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Sylmar, California (8.0 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
California Eye Specialists Medical group Inc. — Pasadena, California (27.4 mi)
· Sponsor: Genentech, Inc.
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
California Research Institute — Los Angeles, California (29.1 mi)
· Sponsor: OncoNano Medicine, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: National Cancer Institute (NCI)
Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy
Chronic Maxillary Rhinosinusitis
Phase 2, Phase 3
Interventional 50 participants sought
Cedars Sinai — Los Angeles, California (29.1 mi)
· Sponsor: Cedars-Sinai Medical Center
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Clinical Research Institute, LCC — Los Angeles, California (29.1 mi)
· Sponsor: AbbVie
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
Open Surgery, Lymphedema
N/A
Observational 455 participants sought
Cedars Sinai Medical Center — Beverly Hills, California (24.4 mi)
· Sponsor: MMI (Medical Microinstruments, Inc.)
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Disney Family Cancer Center — Burbank, California (19.5 mi)
· Sponsor: Hoffmann-La Roche
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Keck Medical Center of USC — Los Angeles, California (29.1 mi)
· Sponsor: Jaeb Center for Health Research